METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY

As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with anima l grafts and it takes the following steps: A) Deuterium Depleted Water administering to Wistar outbred rats by diet, with concentrations of 25 ppm D2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TRAICU, RODIN, BALINT, EMILIA, NICULITA, PETRU, COMISEL, VIRGILIU, TERBEA, IOAN, ENCUT, IOAN, BEGU, DANIELA, VALECA, SERBAN CONSTANTIN, MANOLESCU, NICOLAE, POP, ANETA, MORARU, VICTORIA, MATEESCU, CORNELIU, PANAIT, MARIETA, BALANESCU, ION, STEFANESCU, IOAN, MARCULESCU, DUMITRU, CINCA, SABIN, GRUIA, MARIA-IULIANA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TRAICU, RODIN
BALINT, EMILIA
NICULITA, PETRU
COMISEL, VIRGILIU
TERBEA, IOAN
ENCUT, IOAN
BEGU, DANIELA
VALECA, SERBAN CONSTANTIN
MANOLESCU, NICOLAE
POP, ANETA
MORARU, VICTORIA
MATEESCU, CORNELIU
PANAIT, MARIETA
BALANESCU, ION
STEFANESCU, IOAN
MARCULESCU, DUMITRU
CINCA, SABIN
GRUIA, MARIA-IULIANA
description As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with anima l grafts and it takes the following steps: A) Deuterium Depleted Water administering to Wistar outbred rats by diet, with concentrations of 25 ppm D2, 60 ppm D2, and 100 ppm D2, over a period of 60 days, simultaneously to dieting a control group of animals with water having 150 ppm content of Deuterium (tap water), over the same period of time. B) Viability determination for the tumor cells to be grafted, using tripan blue C) Grafti ng of the animals in the experimental group and the control animals in the 60th day, subcutaneous, with 1 x 107 malign tumor cells in 0.5 cc of normal salin e solution of 256 Walker sarcoma (the solid tumor), and T8 Guérinlymphotropic epitelioma (the solid tumor) both of them having cells with a viability over 98%. D) Continuously and long-term administering, by diet, of Deuterium Depleted Water, with concentrations of 25 ppm, 60 ppm, 100 ppm Deuterium, period over which the followings are to be done: a. Starting with the 4thpos t- graft day the tumor nodules measurement and examination is performed on each 2- 3 days; b. Monitoring of animals' physiological condition by weekly weighing , monitoring their food and waterconsumption, notifying the toxic condition occurrence c. After 60 days, when all the animals in control group are dead, preferable between the 160th and 200th day after graft, the effect produced by administering of established concentrations of Deuterium Depleted Water is observed on the surviving animals homeostasis from experimental groups, respectively the way how humoral immune system and cellular immune system of these animals has been influenced, by performing of a series of examination on immunological condition of the animals, namely: leucocytes formula test to establish lymphocytes and blastic cells levels; hematopoietic marrow tests t o establish the plasmocytes and NK-K cells levels. Also, was established the level of the competent immunologic cells in the lymph nods of the tumoral graft zona. E) Determination of efficient concentration of Deuterium Deplete d Water for tested surviving animals depending on new homeostasis occurrence, and on the results obtained related to, tumoral regression, as well as on cancer curing cases. This method determines the 60 ppm concentration of Deuterium Depleted Water to be the most efficient for cancer therapy and proph
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2525624A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2525624A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2525624A13</originalsourceid><addsrcrecordid>eNqNjUEKwjAQRbtxIeod5gIurNb9kEzoQJOUdFpxVYrElWihHsCjm0oPIHz4n-H_N-vsY0lKr8H4AOyg486DJqFg2aGwd5Ak1AhpQMcWqwa8ASkJyBhWTE5AeaeSh2VgEqFNCG5tSnVF8_iC6fJ7ozC1w4wIWF-32eo-PKa4W3yTgSFR5T6Orz5O43CLz_juFeZFXpzzEx6Of1S-2t47fw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY</title><source>esp@cenet</source><creator>TRAICU, RODIN ; BALINT, EMILIA ; NICULITA, PETRU ; COMISEL, VIRGILIU ; TERBEA, IOAN ; ENCUT, IOAN ; BEGU, DANIELA ; VALECA, SERBAN CONSTANTIN ; MANOLESCU, NICOLAE ; POP, ANETA ; MORARU, VICTORIA ; MATEESCU, CORNELIU ; PANAIT, MARIETA ; BALANESCU, ION ; STEFANESCU, IOAN ; MARCULESCU, DUMITRU ; CINCA, SABIN ; GRUIA, MARIA-IULIANA</creator><creatorcontrib>TRAICU, RODIN ; BALINT, EMILIA ; NICULITA, PETRU ; COMISEL, VIRGILIU ; TERBEA, IOAN ; ENCUT, IOAN ; BEGU, DANIELA ; VALECA, SERBAN CONSTANTIN ; MANOLESCU, NICOLAE ; POP, ANETA ; MORARU, VICTORIA ; MATEESCU, CORNELIU ; PANAIT, MARIETA ; BALANESCU, ION ; STEFANESCU, IOAN ; MARCULESCU, DUMITRU ; CINCA, SABIN ; GRUIA, MARIA-IULIANA</creatorcontrib><description>As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with anima l grafts and it takes the following steps: A) Deuterium Depleted Water administering to Wistar outbred rats by diet, with concentrations of 25 ppm D2, 60 ppm D2, and 100 ppm D2, over a period of 60 days, simultaneously to dieting a control group of animals with water having 150 ppm content of Deuterium (tap water), over the same period of time. B) Viability determination for the tumor cells to be grafted, using tripan blue C) Grafti ng of the animals in the experimental group and the control animals in the 60th day, subcutaneous, with 1 x 107 malign tumor cells in 0.5 cc of normal salin e solution of 256 Walker sarcoma (the solid tumor), and T8 Guérinlymphotropic epitelioma (the solid tumor) both of them having cells with a viability over 98%. D) Continuously and long-term administering, by diet, of Deuterium Depleted Water, with concentrations of 25 ppm, 60 ppm, 100 ppm Deuterium, period over which the followings are to be done: a. Starting with the 4thpos t- graft day the tumor nodules measurement and examination is performed on each 2- 3 days; b. Monitoring of animals' physiological condition by weekly weighing , monitoring their food and waterconsumption, notifying the toxic condition occurrence c. After 60 days, when all the animals in control group are dead, preferable between the 160th and 200th day after graft, the effect produced by administering of established concentrations of Deuterium Depleted Water is observed on the surviving animals homeostasis from experimental groups, respectively the way how humoral immune system and cellular immune system of these animals has been influenced, by performing of a series of examination on immunological condition of the animals, namely: leucocytes formula test to establish lymphocytes and blastic cells levels; hematopoietic marrow tests t o establish the plasmocytes and NK-K cells levels. Also, was established the level of the competent immunologic cells in the lymph nods of the tumoral graft zona. E) Determination of efficient concentration of Deuterium Deplete d Water for tested surviving animals depending on new homeostasis occurrence, and on the results obtained related to, tumoral regression, as well as on cancer curing cases. This method determines the 60 ppm concentration of Deuterium Depleted Water to be the most efficient for cancer therapy and prophylaxis by continuously and long-term administering of this type of wate r in daily diet.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TESTING</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050224&amp;DB=EPODOC&amp;CC=CA&amp;NR=2525624A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050224&amp;DB=EPODOC&amp;CC=CA&amp;NR=2525624A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TRAICU, RODIN</creatorcontrib><creatorcontrib>BALINT, EMILIA</creatorcontrib><creatorcontrib>NICULITA, PETRU</creatorcontrib><creatorcontrib>COMISEL, VIRGILIU</creatorcontrib><creatorcontrib>TERBEA, IOAN</creatorcontrib><creatorcontrib>ENCUT, IOAN</creatorcontrib><creatorcontrib>BEGU, DANIELA</creatorcontrib><creatorcontrib>VALECA, SERBAN CONSTANTIN</creatorcontrib><creatorcontrib>MANOLESCU, NICOLAE</creatorcontrib><creatorcontrib>POP, ANETA</creatorcontrib><creatorcontrib>MORARU, VICTORIA</creatorcontrib><creatorcontrib>MATEESCU, CORNELIU</creatorcontrib><creatorcontrib>PANAIT, MARIETA</creatorcontrib><creatorcontrib>BALANESCU, ION</creatorcontrib><creatorcontrib>STEFANESCU, IOAN</creatorcontrib><creatorcontrib>MARCULESCU, DUMITRU</creatorcontrib><creatorcontrib>CINCA, SABIN</creatorcontrib><creatorcontrib>GRUIA, MARIA-IULIANA</creatorcontrib><title>METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY</title><description>As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with anima l grafts and it takes the following steps: A) Deuterium Depleted Water administering to Wistar outbred rats by diet, with concentrations of 25 ppm D2, 60 ppm D2, and 100 ppm D2, over a period of 60 days, simultaneously to dieting a control group of animals with water having 150 ppm content of Deuterium (tap water), over the same period of time. B) Viability determination for the tumor cells to be grafted, using tripan blue C) Grafti ng of the animals in the experimental group and the control animals in the 60th day, subcutaneous, with 1 x 107 malign tumor cells in 0.5 cc of normal salin e solution of 256 Walker sarcoma (the solid tumor), and T8 Guérinlymphotropic epitelioma (the solid tumor) both of them having cells with a viability over 98%. D) Continuously and long-term administering, by diet, of Deuterium Depleted Water, with concentrations of 25 ppm, 60 ppm, 100 ppm Deuterium, period over which the followings are to be done: a. Starting with the 4thpos t- graft day the tumor nodules measurement and examination is performed on each 2- 3 days; b. Monitoring of animals' physiological condition by weekly weighing , monitoring their food and waterconsumption, notifying the toxic condition occurrence c. After 60 days, when all the animals in control group are dead, preferable between the 160th and 200th day after graft, the effect produced by administering of established concentrations of Deuterium Depleted Water is observed on the surviving animals homeostasis from experimental groups, respectively the way how humoral immune system and cellular immune system of these animals has been influenced, by performing of a series of examination on immunological condition of the animals, namely: leucocytes formula test to establish lymphocytes and blastic cells levels; hematopoietic marrow tests t o establish the plasmocytes and NK-K cells levels. Also, was established the level of the competent immunologic cells in the lymph nods of the tumoral graft zona. E) Determination of efficient concentration of Deuterium Deplete d Water for tested surviving animals depending on new homeostasis occurrence, and on the results obtained related to, tumoral regression, as well as on cancer curing cases. This method determines the 60 ppm concentration of Deuterium Depleted Water to be the most efficient for cancer therapy and prophylaxis by continuously and long-term administering of this type of wate r in daily diet.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUEKwjAQRbtxIeod5gIurNb9kEzoQJOUdFpxVYrElWihHsCjm0oPIHz4n-H_N-vsY0lKr8H4AOyg486DJqFg2aGwd5Ak1AhpQMcWqwa8ASkJyBhWTE5AeaeSh2VgEqFNCG5tSnVF8_iC6fJ7ozC1w4wIWF-32eo-PKa4W3yTgSFR5T6Orz5O43CLz_juFeZFXpzzEx6Of1S-2t47fw</recordid><startdate>20050224</startdate><enddate>20050224</enddate><creator>TRAICU, RODIN</creator><creator>BALINT, EMILIA</creator><creator>NICULITA, PETRU</creator><creator>COMISEL, VIRGILIU</creator><creator>TERBEA, IOAN</creator><creator>ENCUT, IOAN</creator><creator>BEGU, DANIELA</creator><creator>VALECA, SERBAN CONSTANTIN</creator><creator>MANOLESCU, NICOLAE</creator><creator>POP, ANETA</creator><creator>MORARU, VICTORIA</creator><creator>MATEESCU, CORNELIU</creator><creator>PANAIT, MARIETA</creator><creator>BALANESCU, ION</creator><creator>STEFANESCU, IOAN</creator><creator>MARCULESCU, DUMITRU</creator><creator>CINCA, SABIN</creator><creator>GRUIA, MARIA-IULIANA</creator><scope>EVB</scope></search><sort><creationdate>20050224</creationdate><title>METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY</title><author>TRAICU, RODIN ; BALINT, EMILIA ; NICULITA, PETRU ; COMISEL, VIRGILIU ; TERBEA, IOAN ; ENCUT, IOAN ; BEGU, DANIELA ; VALECA, SERBAN CONSTANTIN ; MANOLESCU, NICOLAE ; POP, ANETA ; MORARU, VICTORIA ; MATEESCU, CORNELIU ; PANAIT, MARIETA ; BALANESCU, ION ; STEFANESCU, IOAN ; MARCULESCU, DUMITRU ; CINCA, SABIN ; GRUIA, MARIA-IULIANA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2525624A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>TRAICU, RODIN</creatorcontrib><creatorcontrib>BALINT, EMILIA</creatorcontrib><creatorcontrib>NICULITA, PETRU</creatorcontrib><creatorcontrib>COMISEL, VIRGILIU</creatorcontrib><creatorcontrib>TERBEA, IOAN</creatorcontrib><creatorcontrib>ENCUT, IOAN</creatorcontrib><creatorcontrib>BEGU, DANIELA</creatorcontrib><creatorcontrib>VALECA, SERBAN CONSTANTIN</creatorcontrib><creatorcontrib>MANOLESCU, NICOLAE</creatorcontrib><creatorcontrib>POP, ANETA</creatorcontrib><creatorcontrib>MORARU, VICTORIA</creatorcontrib><creatorcontrib>MATEESCU, CORNELIU</creatorcontrib><creatorcontrib>PANAIT, MARIETA</creatorcontrib><creatorcontrib>BALANESCU, ION</creatorcontrib><creatorcontrib>STEFANESCU, IOAN</creatorcontrib><creatorcontrib>MARCULESCU, DUMITRU</creatorcontrib><creatorcontrib>CINCA, SABIN</creatorcontrib><creatorcontrib>GRUIA, MARIA-IULIANA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TRAICU, RODIN</au><au>BALINT, EMILIA</au><au>NICULITA, PETRU</au><au>COMISEL, VIRGILIU</au><au>TERBEA, IOAN</au><au>ENCUT, IOAN</au><au>BEGU, DANIELA</au><au>VALECA, SERBAN CONSTANTIN</au><au>MANOLESCU, NICOLAE</au><au>POP, ANETA</au><au>MORARU, VICTORIA</au><au>MATEESCU, CORNELIU</au><au>PANAIT, MARIETA</au><au>BALANESCU, ION</au><au>STEFANESCU, IOAN</au><au>MARCULESCU, DUMITRU</au><au>CINCA, SABIN</au><au>GRUIA, MARIA-IULIANA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY</title><date>2005-02-24</date><risdate>2005</risdate><abstract>As per invention embodiment, the method provides Deuterium Depleted Water administering to tested animals before and after tumoral grafting with anima l grafts and it takes the following steps: A) Deuterium Depleted Water administering to Wistar outbred rats by diet, with concentrations of 25 ppm D2, 60 ppm D2, and 100 ppm D2, over a period of 60 days, simultaneously to dieting a control group of animals with water having 150 ppm content of Deuterium (tap water), over the same period of time. B) Viability determination for the tumor cells to be grafted, using tripan blue C) Grafti ng of the animals in the experimental group and the control animals in the 60th day, subcutaneous, with 1 x 107 malign tumor cells in 0.5 cc of normal salin e solution of 256 Walker sarcoma (the solid tumor), and T8 Guérinlymphotropic epitelioma (the solid tumor) both of them having cells with a viability over 98%. D) Continuously and long-term administering, by diet, of Deuterium Depleted Water, with concentrations of 25 ppm, 60 ppm, 100 ppm Deuterium, period over which the followings are to be done: a. Starting with the 4thpos t- graft day the tumor nodules measurement and examination is performed on each 2- 3 days; b. Monitoring of animals' physiological condition by weekly weighing , monitoring their food and waterconsumption, notifying the toxic condition occurrence c. After 60 days, when all the animals in control group are dead, preferable between the 160th and 200th day after graft, the effect produced by administering of established concentrations of Deuterium Depleted Water is observed on the surviving animals homeostasis from experimental groups, respectively the way how humoral immune system and cellular immune system of these animals has been influenced, by performing of a series of examination on immunological condition of the animals, namely: leucocytes formula test to establish lymphocytes and blastic cells levels; hematopoietic marrow tests t o establish the plasmocytes and NK-K cells levels. Also, was established the level of the competent immunologic cells in the lymph nods of the tumoral graft zona. E) Determination of efficient concentration of Deuterium Deplete d Water for tested surviving animals depending on new homeostasis occurrence, and on the results obtained related to, tumoral regression, as well as on cancer curing cases. This method determines the 60 ppm concentration of Deuterium Depleted Water to be the most efficient for cancer therapy and prophylaxis by continuously and long-term administering of this type of wate r in daily diet.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2525624A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
title METHOD FOR IN VIVO DETERMINATION ON TESTED ANIMALS OF THE EFFICIENT CONCENTRATION OF DEUTERIUM DEPLETED WATER FOR CANCER THERAPY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A39%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TRAICU,%20RODIN&rft.date=2005-02-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2525624A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true